Patents by Inventor Ekaterina Aleksandrovna LOMKOVA

Ekaterina Aleksandrovna LOMKOVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AQUEOUS PHARMACEUTICAL COMPOSITION OF LEVILIMAB
    Publication number: 20230203171
    Abstract: The disclosure relates to the field of pharmacy and medicine, specifically to aqueous compositions of anti-IL-6R antibody levilimab which may be used as a medicinal product for treating IL-6R-associated diseases.
    Type: Application
    Filed: June 7, 2021
    Publication date: June 29, 2023
    Inventors: Dmitrii Aleksandrovich TOLSTYKH, Alina Aleksandrovna TSUKUR, Ekaterina Aleksandrovna LOMKOVA, Aleksandr Olegovich IAKOVLEV, Anton Aleksandrovich LUTCKII, Iuliia Nikolaevna LINKOVA, Arina Valerevna ZINKINA-ORIKHAN, Dmitry Valentinovich MOROZOV
  • AQUEOUS PHARMACEUTICAL COMPOSITION OF AN ANTI-IL17A ANTIBODY AND USE THEREOF
    Publication number: 20220372127
    Abstract: The present disclosure relates to aqueous compositions for anti-IL17a antibodies, and more particularly to aqueous compositions for anti-IL17a antibodies with a VHH variable domain and a VL variable domain, and can be used as a medicinal agent for treating IL-17A-mediated diseases.
    Type: Application
    Filed: April 2, 2020
    Publication date: November 24, 2022
    Inventors: Ekaterina Valerevna CHERNIAEVA, Ekaterina Aleksandrovna LOMKOVA, Antonina Vasilevna ARTEMEVA, Anna Viktorovna EREMEEVA, Roman Alekseevich IVANOV, Anastasiya Mikhajlovna RYAKHOVSKAYA, Viktoriia Olegovna SHITIKOVA, Aleksandr Olegovich IAKOVLEV, Dmitry Valentinovich MOROZOV
  • Trispecific antibodies against IL-17A, IL-17F and other pro-inflammatory molecule
    Patent number: 11453717
    Abstract: The present invention relates to the field of biotechnology and provides monoclonal tri-specific binding molecules that specifically bind to human IL-17A, human IL-17F, and a human pro-inflammatory molecule (in particular, TNF?) with high affinity. The invention also relates to DNA constructs encoding said binding molecules, related expression vectors and methods of production, and methods of treatment using said binding molecules.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: September 27, 2022
    Inventors: Dmitry Valentinovich Morozov, Andrei Borisovich Ulitin, Ekaterina Sergeevna Zubareva, Iakov Iurevich Ustiugov, Aleksandr Vladimirovich Karabelskii, Dmitry Valeryevich Korzhavin, Tatiana Veniaminovna Chernovskaya, Aleksandr Valerevich Grachev, Yury Ivanovich Basovskiy, Ekaterina Aleksandrovna Lomkova, Veronika Sergeevna Usatova, Aleksei Aleksandrovich Aleksandrov, Elena Leonidovna Morozova, Roman Alekseevich Ivanov, Pavel Andreevich Iakovlev
  • TRISPECIFIC ANTIBODIES AGAINST IL-17A, IL-17F AND OTHER PRO-INFLAMMATORY MOLECULE
    Publication number: 20210332120
    Abstract: The present invention relates to the field of biotechnology and provides monoclonal tri-specific binding molecules that specifically bind to human IL-17A, human IL-17F, and a human pro-inflammatory molecule (in particular, TNF?) with high affinity. The invention also relates to DNA constructs encoding said binding molecules, related expression vectors and methods of production, and methods of treatment using said binding molecules.
    Type: Application
    Filed: December 2, 2016
    Publication date: October 28, 2021
    Inventors: Dmitry Valentinovich MOROZOV, Andrei Borisovich ULITIN, Ekaterina Sergeevna ZUBAREVA, Iakov Iurevich USTIUGOV, Aleksandr Vladimirovich KARABELSKII, Dmitry Valeryevich KORZHAVIN, Tatiana Veniaminovna CHERNOVSKAYA, Aleksandr Valerevich GRACHEV, Yury Ivanovich BASOVSKIY, Ekaterina Aleksandrovna LOMKOVA, Veronika Sergeevna USATOVA, Aleksei Aleksandrovich ALEKSANDROV, Elena Leonidovna MOROZOVA, Roman Alekseevich IVANOV, Pavel Andreevich IAKOVLEV